Three organisations have joined together to launch new guidelines to safeguard pupils with allergies while they are at school.
The Anaphylaxis Campaign, Allergy UK and the British Society of Allergy and Clinical Immunology have collaborated to develop the Model Policy for Allergy Management at School Guidelines.
The guidelines, said Allergy UK, provide clear and specific guidance on how to develop and implement allergy policies which recognise children at risk, include measures to minimise risk, and define what constitutes adequate training for staff. They will also help all school staff to recognise the symptoms of anaphylaxis, administer adrenaline early and encourage a whole-school approach to allergy management.
Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.